Analyze Diet

Topic:Vaccination

Vaccination in horses involves the administration of antigenic material to stimulate an immune response, providing protection against specific infectious diseases. This process is a key component of preventive equine healthcare, aiming to reduce the incidence and severity of illnesses such as equine influenza, tetanus, and West Nile virus. Vaccines can be administered via various routes and may contain live attenuated, inactivated, or subunit components. The immune response elicited by vaccination helps in the development of immunological memory, enabling horses to respond more effectively upon exposure to the actual pathogen. This page compiles peer-reviewed research studies and scholarly articles that explore the development, efficacy, and safety of vaccines in equine populations.
Venezuelan equine encephalomyelitis: antibody response in vaccinated horses and resistance to infection with virulent virus.
Journal of the American Veterinary Medical Association    February 15, 1973   Volume 162, Issue 4 280-283 
Jochim MM, Barber TL, Luedke AJ.No abstract available
Persistence of neutralizing antibody in Equidae vaccinated with Venezuelan equine encephalomyelitis vaccine strain TC-83.
Journal of the American Veterinary Medical Association    October 15, 1972   Volume 161, Issue 8 916-918 
Walton TE, Johnson KM.No abstract available
Effect of back passage of Venezuelan equine encephalomyelitis TC-83 vaccine virus on clinical, virologic, and immune responses in horses.
Journal of the American Veterinary Medical Association    October 1, 1972   Volume 161, Issue 7 824-831 
Luedke AJ, Barber TL, Foster NM, Batalla D, Mercado S.No abstract available
Effect of back passage of Venezuelan equine encephalomyelitis vaccine (TC-83) on the central nervous system of horses.
Journal of the American Veterinary Medical Association    October 1, 1972   Volume 161, Issue 7 832-833 
Monlux WS, Luedke AJ, Mercado S, Rosales JC, Rios R.No abstract available
Central nervous system response of horses to Venezuelan equine encephalomyelitis vaccine (TC-83).
Journal of the American Veterinary Medical Association    August 1, 1972   Volume 161, Issue 3 265-269 
Monlux WS, Luedke AJ, Bowne J.No abstract available
A study of different equine influenza vaccination schedules in seronegative foals and in horses.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    July 1, 1972   Volume 20, Issue 5 361-366 doi: 10.1111/j.1439-0450.1973.tb01137.x
Petermann HG, Stellmann C, Graveline P.No abstract available
Experimental infection of horses with an attenuated Venezuelan equine encephalomyelitis vaccine (strain TC-83).
Infection and immunity    May 1, 1972   Volume 5, Issue 5 750-756 doi: 10.1128/iai.5.5.750-756.1972
Walton TE, Alvarez O, Buckwalter RM, Johnson KM.Ten horses (Equus caballus) were vaccinated with strain TC-83 Venezuelan equine encephalomyelitis (VEE) virus vaccine. Febrile responses and leukopenia due to a reduction of lymphocytes and neutrophils were observed in all animals. Viremias were demonstrable in eight horses, with a maximum of 10(3.5) median tissue culture infectious dose units per ml of serum in two horses. Clinical illness with depression and anorexia were observed in five horses. Neutralizing (N), hemagglutination-inhibiting, and complement-fixing antibodies to the vaccine virus were demonstrable by 5, 6.5, and 7 days, respe...
Heat-labile factor necessary for hemagglutination-inhibition testing of horse sera.
Applied microbiology    May 1, 1971   Volume 21, Issue 5 860-861 doi: 10.1128/am.21.5.860-861.1971
DeMeio JL, DeSanctis AN.Normal and immune sera were obtained from horses immunized with either aqueous, alum, or adjuvant bivalent vaccines containing Milford equine 2 virus. Upon heating at 56 C for 30 min, a factor, required for hemagglutination-inhibition but not complement fixation or neutralization testing, was destroyed. This factor which is present in normal sera does not appear to be complement.
Guidelines for the control of equine viral infections.
Equine veterinary journal    January 1, 1971   Volume 3, Issue 1 1-6 doi: 10.1111/j.2042-3306.1971.tb04431.x
Scott GR.Twelve DNA viruses and forty‐three RNA viruses are known to infect horses. In addition, there are three unclassified viruses and, at least, three alleged viruses infecting horses. Differential diagnosis is difficult. At least twenty‐eight of the fifty‐eight viruses induce clinical disease but the range of syndromes is limited; eleven provoke respiratory symptoms and eleven cause encephalitis. Thirty‐four equine viruses with a limited geographical distribution are transmitted by arthropod vectors. Twenty viruses are spread by contact and their distribution, in general, is global. The ve...
[Serologic studies following influenza immunization of horses. II. Reimmunization 1 year after the initial vaccination].
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    December 1, 1970   Volume 17, Issue 10 1003-1009 
Pressler K.No abstract available
Hyperimmunization of horses with alpha toxoid of Clostridium perfringens.
Japanese journal of medical science & biology    April 1, 1970   Volume 23, Issue 2 111-115 doi: 10.7883/yoken1952.23.111
Yanamoto A, Ito A, Murata R, Uematsu N, Nagai K.No abstract available
The response of ponies to Myxovirus influenzae A-equi 2. I. Serum and nasal antibody titres following exposure. Rouse BT, Ditchfield WJ.The antibody response in serum and nasal secretions of groups of ponies vaccinated or infected with Myxovirus influenzae A-equi 2 was examined. Following infection by aerosol with live virus, a weak antibody response was recorded in both serum and secretions. Antibody levels were undetectable in secretions at 31 days after infection. After primary intramuscular vaccination with killed virus, using sodium alginate as an adjuvant, antibody was detected only in the serum. However, following revaccination, a pronounced antibody response was demonstrated in both serum and secretions. Antibody was s...
[Rabies vaccination of the horse].
Berliner und Munchener tierarztliche Wochenschrift    September 15, 1969   Volume 82, Issue 18 341-342 
Jaeger O, Barth R.No abstract available
[Immunization of horses against rhinopneumonitis (equine virus abortion) with porcine-testicle-cell adapted live virus].
Wiener tierarztliche Monatsschrift    September 1, 1969   Volume 56, Issue 7 275-280 
Kubin G, Kölbl O.No abstract available
Comments on biologic requirements and control of equine rhinopneumonitis vaccine.
Journal of the American Veterinary Medical Association    July 15, 1969   Volume 155, Issue 2 312-314 
Bittle JL.No abstract available
Biologic requirements and control for equine encephalomyelitis vaccines.
Journal of the American Veterinary Medical Association    July 15, 1969   Volume 155, Issue 2 376-379 
Tamoglia TW.No abstract available
Comments on the immunology of equine influenza.
Journal of the American Veterinary Medical Association    July 15, 1969   Volume 155, Issue 2 272-277 
Todd JD.No abstract available
Mixed equine bacterins.
Journal of the American Veterinary Medical Association    July 15, 1969   Volume 155, Issue 2 432 
Phillips CE.No abstract available
Comparison of HI antibody response in horses vaccinated with vaccines prepared with A-2-equi-Alfort-65 and A-2-equi-Miami-63 influenza viruses.
The Cornell veterinarian    January 1, 1969   Volume 59, Issue 1 29-34 
Wilson JC.No abstract available
[Studies on the development of a live vaccine against rhinopneumonitis (mare abortion) of horses]. Mayr A, Pette J, Petzoldt K, Wagener K.No abstract available
A safety test for Eastern equine encephalomyelitis vaccine.
Applied microbiology    July 1, 1967   Volume 15, Issue 4 968-969 doi: 10.1128/am.15.4.968-969.1967
Berman S, Lowenthal JP, Sorrentino JV, White AB.No abstract available
Post-vaccination reactions in donkeys vaccinated with African horse-sickness polyvalent vaccines.
Bulletin - Office international des epizooties    July 1, 1967   Volume 67, Issue 7 949-959 
Ozawa Y, Hazrati A.No abstract available
African horse-sickness killed-virus tissue culture vaccine.
Canadian journal of comparative medicine and veterinary science    November 1, 1966   Volume 30, Issue 11 311-314 
Ozawa Y, Bahrami S.Formalized African horse-sickness (AHS) type 9 virus cultivated in monkey kidney stable (MS) cell cultures was experimentally used for immunizing horses. Inactivated vaccines prepared either from viscerotropic or neurotropic type 9 AHS virus produced antibodies in vaccinated horses. Immunity developed in all horses vaccinated with various amounts of the vaccine, and protected them from infection, when challenged 5 weeks after vaccination.
Immunizing horses against rabies.
Journal of the American Veterinary Medical Association    November 1, 1966   Volume 149, Issue 9 1159-1161 
Marx MB, Sikes RK.No abstract available
Increase production of diphtheria antitoxin in horses.
Indian journal of medical sciences    September 1, 1966   Volume 20, Issue 9 644-646 
Chatterjee SC.No abstract available
Prophylaxis of tetanus in horses.
Journal of the American Veterinary Medical Association    February 15, 1966   Volume 148, Issue 4 399-404 
Fessler JF.No abstract available
[Serologic Response of the Horse to Injection of Human and Equine Type A Strains of Influenza Virus].
Revue canadienne de biologie    September 1, 1964   Volume 23 285-289 
MAROIS P, PAVILANIS V, GILKER JC.No abstract available
Production of Hyperimmune Antirabies Serum in Horses.
Bulletin of the World Health Organization    January 1, 1964   Volume 30, Issue 3 437-439 
FUENZALIDA E.No abstract available
Leptospirosis vaccination studies in cattle, swine, sheep, and horses.
Journal of the American Veterinary Medical Association    October 15, 1957   Volume 131, Issue 8 366-368 
SCHEIDY SF.No abstract available
[Modifications of blood glycoprotein levels during immunization by tetanus anatoxin in horse].
Comptes rendus hebdomadaires des seances de l'Academie des sciences    August 12, 1957   Volume 245, Issue 7 810-812 
DELAUNAY A, HENON M, BRUYET P, MEIGNIEN C, RECULARD P.No abstract available